Low Temperature Plasma Suppresses Lung Cancer Cells Growth Via VEGF/VEGFR2/RAS/ERK Axis
Affiliations
Low temperature plasma (LTP) is a promising cancer therapy in clinical practice. In this study, dielectric barrier discharge plasma with helium gas was used to generate LTP. Significant increases in extracellular and intracellular reactive species were found in lung cancer cells (CALU-1 and SPC-A1) after LTP treatments. Cells viability and apoptosis assays demonstrated that LTP inhibited cells viability and induced cells death, respectively. Moreover, Western blotting revealed that the growth of CALU-1 cells was suppressed by LTP via the VEGF/VEGFR2/RAS/ERK axis for the first time. The results showed that LTP-induced ROS and RNS could inhibit the growth of lung cancer cells via VEGF/VEGFR2/RAS/ERK axis. These findings advance our understanding of the inhibitory mechanism of LTP on lung cancer and will facilitate its clinical application.
Sun Z, Ding C, Wang Y, Lu T, Song W Int J Mol Sci. 2025; 25(24.
PMID: 39769029 PMC: 11676436. DOI: 10.3390/ijms252413262.
Yang Y, Wang Y, Wei S, Wang X, Zhang J Int J Mol Sci. 2023; 24(21).
PMID: 37958872 PMC: 10648079. DOI: 10.3390/ijms242115889.
Current Status and Future Trends of Cold Atmospheric Plasma as an Oncotherapy.
Dai X, Wu J, Lu L, Chen Y Biomol Ther (Seoul). 2023; 31(5):496-514.
PMID: 37641880 PMC: 10468422. DOI: 10.4062/biomolther.2023.027.
Zhang Y, Yan Z, Wu H, Yang X, Yang K, Song W Biomolecules. 2023; 13(7).
PMID: 37509109 PMC: 10377075. DOI: 10.3390/biom13071073.